B. Braun pulls spinal anesthesia kits after recall of bupivacaine in dextrose injection

B. Braun Medical, Inc. has issued a recall of several spinal anesthesia convenience kits that contain Huons bupivacaine hydrochloride in dextrose injection. The recall follows a request from Huons Co., Ltd. and has been classified by the FDA as the most serious type because continued use could cause serious injury or death.

The affected items include the PENCAN Spinal Needle Procedure Kits, Spinocan Spinal Needle Procedure Kits, and Spinocan Spinal Tray Spinal Needle Anesthesia Procedure Kits. These kits were distributed to hospitals and other healthcare facilities.

B. Braun sent a letter to all customers on April 26 advising them to immediately check inventory, stop using the kits, quarantine any remaining stock, and return the products to the company. Recipients are also instructed to forward the notice to any downstream consignees.

The recall underscores the importance of vigilance in handling injectable anesthetics, as compromised products can lead to infection, inflammatory reactions, or other serious complications.